Welcome to the OMA Blog

It is critical that health care providers can leverage every tool in the obesity care toolbox to develop the best treatment plan for their patients. Sharing this resource – and resources like it - with your patients can help them understand why coverage may have been denied and what steps they can take to access obesity care. Ensure your clinical care team understands approved indications for obesity medicines and can help patients address coverage challenges quickly2 There are many templates and guides available to help your team understand the latest obesity treatment options and tackle common insurance obstacles to help your patients access care. For example: Learn how and why to code for obesity to document treatment effectively and help your patients gain coverage for needed care. By staying informed and raising your voice, and encouraging your patients to do the same, you can help improve coverage for obesity care.

This article reviews new perioperative guidance on GLP-1RA therapy, emphasizing a team-based approach to reduce surgical risks while supporting continuity of treatment for adolescents with obesity.

The Trump Administration has announced a proposed plan for a five-year pilot program that will allow patients with Medicare or Medicaid access to anti-obesity medications.

This article highlights how obesity in childhood can impair strength, balance, gait, and joint health, emphasizing the importance of routine neuromusculoskeletal screening to support early intervention and improve physical function.

Discover the most effective weight loss medications approved by the FDA. Comprehensive guide on safety, dosage, and efficacy for 2025.

We need an operation warp speed for obesity medicine. Healthcare systems , insurers, and employers are still falling short on our mission of radically changing what obesity looks like in the U.S. and providing access to the full suite of effective obesity treatment interventions including medications that are proven to help patients manage their condition.

At Lilly, we know healthcare providers are looking to us to deliver real medicine—medicine that has been rigorously trialed and tested and that has been manufactured in accordance with the highest standards for safety and quality.

This retrospective study found that in adolescents who had bariatric surgery, standard post-operative care plus early reinitiation of anti-obesity medication (AOM) led to greater weight loss and better eating behaviors than standard post-operative care alone.

Although cardiovascular disease remains a significant concern, many of its risk factors can be managed, and in some cases, even reversed. One of the most effective ways to support heart health is through weight loss.